Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000905729-21-000060
Filing Date
2021-03-05
Accepted
2021-03-05 16:30:12
Documents
2
Group Members
ALEX PETER WOUNLUNDALEXANDER KOCHALEXANDER LUGOVOYALEXANDER PARKERANDREW GRUBERBUXTON HELMSLEY GROUP, INC.BUXTON HELMSLEY HOLDINGS, INC.CHRIS TICHENORDANILIUK KIRILL VLADIMIROVICHDAVID LAMBHANK BEINSTEINISRAEL LARRAONDOJAMES JONATHAN JOSEYJANICE J. O'CONN

Document Format Files

Seq Description Document Type Size
1 BUXTON HELMSLEY-MALLINCKRODT SC 13D buxton-mallinsc13d_030521.htm SC 13D 624346
2 JOINT FILING AGREEMENT buxton-mallinex991_030521.htm EX-99.1 65406
  Complete submission text file 0000905729-21-000060.txt   692320
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Subject) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1225
Type: SC 13D | Act: 34 | File No.: 005-87833 | Film No.: 21718843
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1185 AVENUE OF THE AMERICAS FLOOR 3 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS FLOOR 3 NEW YORK NY 10036 2125615540
Buxton Helmsley Group, Inc. (Filed by) CIK: 0001844298 (see all company filings)

EIN.: 475045339 | State of Incorp.: MI | Fiscal Year End: 1231
Type: SC 13D